NCT03053960

Brief Summary

This clinical trial studies how well helical computed tomography (CT), positron emission tomography (PET)/CT, magnetic resonance imaging (MRI), and cone beam computed tomography (CBCT) work alone or in combination in predicting whether tumor cells have spread to the jaw bone (jaw invasion) in patients with oral cancer. Imaging, such as helical CT, PET/CT, MRI, and CBCT, may help find out how far cancer has spread. Accurate prediction of the presence or absence of jaw invasion may help create a better surgical treatment plan for patients with oral cancer.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
8

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Nov 2015

Typical duration for all trials

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 24, 2015

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

January 31, 2017

Completed
15 days until next milestone

First Posted

Study publicly available on registry

February 15, 2017

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2018

Completed
1.1 years until next milestone

Results Posted

Study results publicly available

December 18, 2019

Completed
Last Updated

April 30, 2025

Status Verified

April 1, 2025

Enrollment Period

2.9 years

First QC Date

January 31, 2017

Results QC Date

October 29, 2019

Last Update Submit

April 28, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Accurate Predication of the Presence or Absence of Bone Invasion by Oral Squamous Cell Carcinoma by Helical CT, PET/CT, MRI and CBCT

    Sensitivity and specificity of the clinical exam, CBCT, helical CT, PET/CT, MRI and any other imaging modality used in detection of bone invasion will be calculated, as compared to the histological examination of the specimens. The positive and negative predictive value will be calculated for each modality using the true positive and negatives as well as false positive and negative values

    Up to 2 years

Secondary Outcomes (1)

  • Incidence of Sparing Resection

    Up to 2 years

Study Arms (1)

Diagnostic (helical CT, PET/CT, MRI, CBCT)

Patients undergo helical (Computed Tomography) CT,(Positron Emission Tomography and Computed Tomography) PET/CT, (Magnetic Resonance Imaging) MRI, and (Cone-Beam Computed Tomography) CBCT scans. Patients also undergo therapeutic conventional surgical resection of tumor.

Device: Computed TomographyDevice: Positron Emission Tomography and Computed Tomography ScanDevice: Cone-Beam Computed TomographyDevice: Magnetic Resonance ImagingProcedure: Therapeutic Conventional SurgeryProcedure: Histopathologic Examination

Interventions

Undergo helical CT scan

Also known as: CAT Scan, Computerized Axial Tomography, CAT
Diagnostic (helical CT, PET/CT, MRI, CBCT)

Undergo PET/CT scan

Also known as: PET-CT Scan, PET/CT SCAN
Diagnostic (helical CT, PET/CT, MRI, CBCT)

Undergo CBCT scan

Diagnostic (helical CT, PET/CT, MRI, CBCT)

Undergo MRI scan

Also known as: MRI, MRI Scan
Diagnostic (helical CT, PET/CT, MRI, CBCT)

Undergo resection of tumor

Diagnostic (helical CT, PET/CT, MRI, CBCT)

Correlative studies

Also known as: Histopathologic Study
Diagnostic (helical CT, PET/CT, MRI, CBCT)

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The data from all of the subjects that are enrolled and have consented to be a part of the study will be analyzed

You may qualify if:

  • Diagnosis of squamous cell carcinoma of the oral cavity
  • Able to read and sign and informed consent

You may not qualify if:

  • Prior mandibular surgery
  • Primary intraosseous carcinoma
  • Prior history of radiation to the mandible
  • Obvious finding of clinical invasion of the mandible

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Links

MeSH Terms

Conditions

Squamous Cell Carcinoma of Head and Neck

Interventions

Tomography, X-Ray ComputedPositron Emission Tomography Computed TomographyCone-Beam Computed TomographyMagnetic Resonance Imaging

Condition Hierarchy (Ancestors)

Carcinoma, Squamous CellCarcinomaNeoplasms, Glandular and EpithelialNeoplasms by Histologic TypeNeoplasmsHead and Neck NeoplasmsNeoplasms by Site

Intervention Hierarchy (Ancestors)

Image Interpretation, Computer-AssistedDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisRadiographic Image EnhancementImage EnhancementPhotographyRadiographyTomography, X-RayTomographyPositron-Emission TomographyTomography, Emission-ComputedMultimodal ImagingRadionuclide ImagingDiagnostic Techniques, Radioisotope

Results Point of Contact

Title
Dr. Lionel Gold
Organization
Sidney Kimmel Cancer Center at Thomas Jefferson University

Study Officials

  • Lionel Gold, MD

    Sidney Kimmel Cancer Center at Thomas Jefferson University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 31, 2017

First Posted

February 15, 2017

Study Start

November 24, 2015

Primary Completion

November 1, 2018

Study Completion

November 1, 2018

Last Updated

April 30, 2025

Results First Posted

December 18, 2019

Record last verified: 2025-04